Abstract:Abstract Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis , a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences.

Deep learning regression model for antimicrobial peptide design

Deep Learning for Novel Antimicrobial Peptide Design

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Deep learning improves antimicrobial peptide recognition

dsAMP and dsAMPGAN: Deep Learning Networks for Antimicrobial Peptides Recognition and Generation

Machine Learning Accelerates De Novo Design of Antimicrobial Peptides

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

Machine learning for antimicrobial peptide identification and design

De novo synthetic antimicrobial peptide design with a recurrent neural network

Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides

Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning

deepAMPNet: a novel antimicrobial peptide predictor employing AlphaFold2 predicted structures and a bi-directional long short-term memory protein language model

Application of a deep generative model produces novel and diverse functional peptides against microbial resistance

Exploring the repository of designed bifunctional antimicrobial peptides through deep learning

Novel Antimicrobial Peptide Design Using Motif Match Score Representation

An ensemble deep learning model for predicting minimum inhibitory concentrations of antimicrobial peptides against pathogenic bacteria

Identification of antimicrobial peptides from the human gut microbiome using deep learning

A Deep Neural Network for Antimicrobial Peptide Recognition

Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria

Antimicrobial Peptide Identification Using Multi-Scale Convolutional Network

Exploring the Repository Ofde Novodesigned Bifunctional Antimicrobial Peptides Through Deep Learning